Abstract
The appropriate amount of oversight for dietary supplements has been a subject of debate for over a decade. This debate has come to a head recently with herbal ephedra, which may be associated with adverse events including heart attack, stroke, seizure, and death. This article reviews and puts into context recent findings on the safety concerns related to ephedra, based primarily on adverse event reports. It presents the response from industry and the FDA in light of this evidence, and describes additional steps taken by other groups who believe that more restrictive action is required. The article concludes by observing the lack of explicit, shared criteria for determining whether a supplement is unsafe, and pointing out ways in which the experience with ephedra can be used constructively to address that problem.
Full Text
The Full Text of this article is available as a PDF (133.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bent Stephen, Tiedt Thomas N., Odden Michelle C., Shlipak Michael G. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003 Mar 18;138(6):468–471. doi: 10.7326/0003-4819-138-6-200303180-00010. [DOI] [PubMed] [Google Scholar]
- Gurley B. J., Gardner S. F., Hubbard M. A. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 2000 May 15;57(10):963–969. doi: 10.1093/ajhp/57.10.963. [DOI] [PubMed] [Google Scholar]
- Haller C. A., Benowitz N. L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000 Dec 21;343(25):1833–1838. doi: 10.1056/NEJM200012213432502. [DOI] [PubMed] [Google Scholar]
- Khatcheressian L. A. Regulation of dietary supplements: five years of DSHEA. Food Drug Law J. 1999;54(4):623–644. [PubMed] [Google Scholar]
- Samenuk David, Link Mark S., Homoud Munther K., Contreras Robert, Theoharides Theoharis C., Wang Paul J., Estes N. A. Mark, 3rd, Theohardes Theoharis C. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 2002 Jan;77(1):12–16. doi: 10.4065/77.1.12. [DOI] [PubMed] [Google Scholar]
- Shekelle Paul G., Hardy Mary L., Morton Sally C., Maglione Margaret, Mojica Walter A., Suttorp Marika J., Rhodes Shannon L., Jungvig Lara, Gagné James. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003 Mar 10;289(12):1537–1545. doi: 10.1001/jama.289.12.1537. [DOI] [PubMed] [Google Scholar]
- Zhang Qunzhou, Wu Yidi, Ann David K., Messadi Diana V., Tuan Tai-Lan, Kelly A. Paul, Bertolami Charles N., Le Anh D. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol. 2003 Nov;121(5):1005–1012. doi: 10.1046/j.1523-1747.2003.12564.x. [DOI] [PubMed] [Google Scholar]